{"id":36681,"date":"2021-10-04T10:19:40","date_gmt":"2021-10-04T09:19:40","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=36681"},"modified":"2021-11-18T15:59:18","modified_gmt":"2021-11-18T15:59:18","slug":"michael-tauber","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/","title":{"rendered":"Michael Tauber"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Michael Tauber<\/h2>\n<h4>Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics<\/h4>\n\t<p>Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics. Since 2002, he has worked in various areas of pharmaceutical development including early and late stage development, pre-formulation and formulation for solid oral development, formulation and scale up of spray dried engineered particles for inhalation delivery and management of CMC related activities supporting the development and commercialization of Inbrija<sup>\u00ae<\/sup>.<\/p>\n<p>Additionally Michael has served at the solid state chemistry technical lead on numerous projects over the years and had established solid state labs as well as instructed many peers on this topic. More recently he has managed all aspects of the extractables and leachables program for Inbrija<sup>\u00ae <\/sup>through NDA\/MAA approval. Michael holds a B.S in Chemistry from UMass Boston and an M.S. in Chemistry from Northeastern University.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery.png\" alt=\"Michael_Tauber_Acorda_BioTech_Pharma_Summit 2021_gallery\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Michael_Tauber_Acorda_BioTech_Pharma_Summit 2021_gallery\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery-420x627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021_gallery-315x470.png 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: &#8220;ARCUS\u00ae: Engineered Spray Dried Particles for Inhalation Delivery&#8221;\n\t<\/h3>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"http:\/\/www.acorda.com\/\" target=\"_blank\" rel=\"noopener\">http:\/\/www.acorda.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/michael-tauber-9133a816\/\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Michael Tauber Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics. Since 2002, he has worked in various areas of pharmaceutical development including early and late stage development, pre-formulation and formulation for solid oral development, formulation and scale up&#8230;<\/p>\n","protected":false},"author":1,"featured_media":36683,"parent":15585,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-36681","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Michael Tauber &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Michael Tauber &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-18T15:59:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/\",\"name\":\"Michael Tauber &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png\",\"datePublished\":\"2021-10-04T09:19:40+00:00\",\"dateModified\":\"2021-11-18T15:59:18+00:00\",\"description\":\"Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inhalation &#038; Respiratory Drug Delivery 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Michael Tauber\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Michael Tauber &#8226; BioTech Pharma Summit","description":"Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/","og_locale":"en_US","og_type":"article","og_title":"Michael Tauber &#8226; BioTech Pharma Summit","og_description":"Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-18T15:59:18+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/","name":"Michael Tauber &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png","datePublished":"2021-10-04T09:19:40+00:00","dateModified":"2021-11-18T15:59:18+00:00","description":"Michael Tauber is Senior Director of Pharmaceutical Development and Technical Operations at Acorda Therapeutics.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/10\/Michael_Tauber_Acorda_BioTech_Pharma_Summit-2021.png","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/michael-tauber\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Inhalation &#038; Respiratory Drug Delivery 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/"},{"@type":"ListItem","position":3,"name":"Michael Tauber"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/36681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=36681"}],"version-history":[{"count":4,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/36681\/revisions"}],"predecessor-version":[{"id":37087,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/36681\/revisions\/37087"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/15585"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/36683"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=36681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}